Home/Filings/4/0001062993-21-002790
4//SEC Filing

McAvoy David R. 4

Accession 0001062993-21-002790

CIK 0000819050other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:53 PM ET

Size

9.0 KB

Accession

0001062993-21-002790

Insider Transaction Report

Form 4
Period: 2021-03-16
McAvoy David R.
General Counsel
Transactions
  • Tax Payment

    Common Stock

    2021-03-16$1.14/sh8,750$9,97592,133 total
  • Exercise/Conversion

    Common Stock

    2021-03-16+25,000100,883 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-03-1625,0000 total
    Common Stock (25,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    6,000
Footnotes (3)
  • [F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
  • [F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.
  • [F3]These RSUs vested in full on March 16, 2021.

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1
  • filerCIK 0001758842

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:53 PM ET
Size
9.0 KB